1. Home
  2. BON vs CDT Comparison

BON vs CDT Comparison

Compare BON & CDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BON
  • CDT
  • Stock Information
  • Founded
  • BON 2006
  • CDT 2019
  • Country
  • BON China
  • CDT United States
  • Employees
  • BON N/A
  • CDT N/A
  • Industry
  • BON Medicinal Chemicals and Botanical Products
  • CDT Biotechnology: Pharmaceutical Preparations
  • Sector
  • BON Health Care
  • CDT Health Care
  • Exchange
  • BON Nasdaq
  • CDT Nasdaq
  • Market Cap
  • BON 5.9M
  • CDT 5.2M
  • IPO Year
  • BON 2021
  • CDT N/A
  • Fundamental
  • Price
  • BON $1.30
  • CDT $1.64
  • Analyst Decision
  • BON
  • CDT
  • Analyst Count
  • BON 0
  • CDT 0
  • Target Price
  • BON N/A
  • CDT N/A
  • AVG Volume (30 Days)
  • BON 183.7K
  • CDT 95.0K
  • Earning Date
  • BON 09-26-2025
  • CDT 08-26-2025
  • Dividend Yield
  • BON N/A
  • CDT N/A
  • EPS Growth
  • BON N/A
  • CDT N/A
  • EPS
  • BON 4.17
  • CDT N/A
  • Revenue
  • BON $23,844,556.00
  • CDT N/A
  • Revenue This Year
  • BON $223.38
  • CDT N/A
  • Revenue Next Year
  • BON $18.82
  • CDT N/A
  • P/E Ratio
  • BON $0.30
  • CDT N/A
  • Revenue Growth
  • BON N/A
  • CDT N/A
  • 52 Week Low
  • BON $1.14
  • CDT $1.61
  • 52 Week High
  • BON $73.75
  • CDT $274.80
  • Technical
  • Relative Strength Index (RSI)
  • BON 42.15
  • CDT 29.41
  • Support Level
  • BON $1.26
  • CDT $1.66
  • Resistance Level
  • BON $1.35
  • CDT $1.85
  • Average True Range (ATR)
  • BON 0.05
  • CDT 0.11
  • MACD
  • BON 0.01
  • CDT 0.03
  • Stochastic Oscillator
  • BON 26.67
  • CDT 8.36

About BON Bon Natural Life Limited

Bon Natural Life Ltd is engaged in the manufacturing of personal care ingredients, such as plants extracted fragrance compounds to perfume and fragrance manufacturers, natural health supplements such as powder drinks and bioactive food ingredient products mostly used as food additives and nutritional supplements. Xi'an App-Chem is devoted to providing high quality and competitive prices and a stable supply of products and services for the functional food, personal care, natural medicine and other industries. It provides these products and services for third party customers, as well as for its own proprietary brands. The company has its geographic presence in PRC and in Overseas. The company derives maximum revenue from Bioactive food ingredients.

About CDT Conduit Pharmaceuticals Inc.

Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being prioritized by biopharmaceutical companies to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready for autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor, and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.

Share on Social Networks: